Latest News
Press Releases
Solaxa Inc. Appoints Brad Navia, MD, PhD as Chief Medical Officer Bethesda, MD; June 27, 2026 –...
Solaxa Inc. Appoints Bill Passer, MBA, as Chief Financial Officer Bethesda, MD; May 15, 2026 –...
Bethesda, MD and Morristown, NJ, February 23, 2026 — Alvogen, a US-based wholly owned...
Solaxa Announces Phase 3 Clinical Trial for Spinocerebellar Ataxia Type 27B Bethesda, MD — March 28...
Solaxa Inc. Announces FDA Clearance of IND Application for SLX-100 Bethesda, MD; January 6, 2024 –...
Solaxa Inc. Collaborates with National Ataxia Foundation Bethesda, MD and Minneapolis, MN;...
Solaxa Inc. Appoints Kerry Clem as Chief Commercial Officer Bethesda, MD; August 19, 2024 –...
U.S. Food and Drug Administration Grants Orphan Drug Designation to Solaxa Inc. ...
Solaxa Inc. Appoints Amy Chappel, MD, FAAN as Chief Medical Officer Bethesda, MD; January 1...
News
Researchers at Penn State College of Medicine and Penn State Health Milton S. Hershey Medical Center are leading a clinical trial to evaluate whether...
When severe injury causes paralysis, the best next step depends on whether nerves have been severed or crushed: unsevered nerves...
- 1
- 2